Variant report
Variant | esv3523859 |
---|---|
Chromosome Location | chr19:55873185-55873386 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:2)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:2 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | POLR2A | chr19:55873343-55882901 | IMR90 | lung: | n/a | n/a |
2 | ZNF263 | chr19:55872696-55873536 | HEK293-T-REx | kidney: | n/a | chr19:55873292-55873313 |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000267706 | TF binding region |
ENSG00000095752 | chromatin interactions |
ENSG00000160471 | chromatin interactions |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs75097423 | chr19:55873192-55873193 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
2 | rs12611363 | chr19:55873193-55873194 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs77816829 | chr19:55873199-55873200 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
4 | rs564896027 | chr19:55873212-55873213 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
5 | rs200174852 | chr19:55873216-55873217 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
6 | rs554337258 | chr19:55873232-55873233 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
7 | rs560111896 | chr19:55873235-55873236 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
8 | rs74889920 | chr19:55873236-55873237 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
9 | rs182899885 | chr19:55873239-55873240 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
10 | rs149483982 | chr19:55873241-55873242 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
11 | rs113570497 | chr19:55873263-55873264 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
12 | rs55724043 | chr19:55873274-55873275 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
13 | rs55852607 | chr19:55873276-55873277 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
14 | rs7409446 | chr19:55873281-55873282 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
15 | rs553822736 | chr19:55873287-55873288 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
16 | rs11084398 | chr19:55873294-55873295 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
17 | rs577184347 | chr19:55873331-55873332 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
18 | rs111466260 | chr19:55873335-55873336 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
19 | rs140715083 | chr19:55873347-55873348 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
20 | rs75956646 | chr19:55873372-55873373 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
21 | rs531072336 | chr19:55873381-55873382 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
22 | rs188402558 | chr19:55873386-55873387 | Weak transcription Genic enhancers Enhancers | TF binding regionChromatin interactive region | 3 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Cancer | 21637783 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Congenital nephrotic syndrome | 18421352 | CNVD |
Astrocytoma | 17934521 | CNVD |
Leukemia | 17361228 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
renal disease | 20603712 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Salivary gland adenoid cystic carcinoma | 17545515 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Chordoma | 18071362 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Bladder cancer | 21909424 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Wilms tumour | 21544195 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18852474 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Cervical cancer | 21062161 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Prostate cancer | 16573809 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20459607 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Myelofibrosis | 22110671 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Alzheimer''s disease | 22166940 | CNVD |
Heart disease | 21282601 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr19:55866200-55880600 | Weak transcription | Right Atrium | heart |
2 | chr19:55869800-55874000 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr19:55870200-55873600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr19:55871400-55877000 | Weak transcription | Foreskin Keratinocyte Primary Cells skin02 | Skin |
5 | chr19:55871400-55880200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr19:55871800-55874200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr19:55872000-55874000 | Weak transcription | H1 Cell Line | embryonic stem cell |
8 | chr19:55872400-55873600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |